VR Logo

Mangalam Drugs & Organics Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

40 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of allopathic pharmaceutical preparations

Incorporated: 1972

Chairman: Govardhan M Dhoot

Managing Director: Govardhan M Dhoot

Group: --

Listing: NSE: MANGALAM, BSE: 532637

Headquarters: Mumbai, Maharashtra

Website: www.mangalamdrugs.com

Key Facts

Market cap: R 158.44 Cr

Revenue (TTM): R 282.35 Cr

Earnings (TTM): R 8.25 Cr

Cash: R 1.43 Cr

Total Debt: R 62.90 Cr

Promoters' ownership: 50.53%

Liquidity: Moderate

52 Week range: R 20.65 - 101.70

Face value: R10.00

Shares outstanding: 1,58,28,248

10 Years Aggregate:

  • CFO: 150.84 Cr
  • EBITDA: 202.58 Cr
  • Net Profit: 45.48 Cr

Stock Performance

Time Period Mangalam Drugs & Organics S&P BSE Healthcare S&P BSE Small Cap
YTD258.1441.271.75
1 month49.6313.929.04
3 months14.6026.2929.38
1 Year193.9850.8311.34
3 Years-9.0713.95-2.49
5 Years4.541.383.80
10 Years20.2613.143.68
As on 13-Aug-2020
Year Mangalam Drugs & Organics S&P BSE Small Cap S&P BSE Healthcare
2019-61.78-6.85-3.55
2018-66.21-23.41-5.89
201763.7159.640.49
2016-34.961.77-12.88
2015882.126.7615.06

Review & Analysis